Portfolio
Aitua is a shareholder in the following companies:
- Altacor Ltd
- Chameleon BioSurfaces Ltd
- Discerna Ltd
- Innova BioSciences Ltd
- Probe Scientific Ltd
- ViraBiotech Ltd
and has exited the following:
Altacor Ltd (Cambridge)
Altacor is a specialty pharmaceutical company building a product portfolio, sales infrastructure and development capability in the area of therapeutic ophthalmology.
Chameleon BioSurfaces Ltd (Cambridge)
Chameleon is developing next generation polymer coatings for implantable medical devices using a unique electro-deposition process.
Discerna Ltd (Babraham Research Campus, Cambridge)
Discerna is a molecular evolution company with a series of powerful next generation platform technologies aimed at major markets within the biotherapeutic, diagnostic and industrial enzyme sectors.
Innova BioSciences Ltd (Babraham Research Campus, Cambridge)
Innova Biosciences develops innovative products and services for drug discovery and basic research. It has particular expertise in fluorescence assay technologies, protein purification, antibody production, protein labelling technologies and immunoassay development, and products in the market include its Lightning-Link™ rapid conjugation kits.
Probe Scientific Ltd (Bedford i-Lab)
Probe is developing a range of products that focus on improving clinical care. The first product, the MicroEye™, is a sterile single-use minimally invasive device which continuously samples and monitors a patient’s blood without removing it from the patient.
ViraBiotech Ltd (University of Warwick)
Virabiotech is developing a totally new approach to combating influenza. “Protecting Flu” offers instant universal protection and converts an invading flu infection into an effective vaccine.
CTM BioTech Ltd (Babraham Research Campus, Cambridge)
CTM BioTech provides contract process scale-up services to bio-pharmaceutical companies and research organisations. In January 2007, CTM was acquired by Alpha Biologics of Malaysia, to form Alpha’s UK division, remaining on the Babraham site.